Literature DB >> 25130193

Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.

Franziska S Hoffmann1, Andreas Schmidt, Meike Dittmann Chevillotte, Christian Wisskirchen, Johannes Hellmuth, Simone Willms, Rachel H Gilmore, Jürgen Glas, Matthias Folwaczny, Tobias Müller, Thomas Berg, Ulrich Spengler, Karen Fitzmaurice, Dermot Kelleher, Nicole Reisch, Charles M Rice, Stefan Endres, Simon Rothenfusser.   

Abstract

UNLABELLED: Among patients newly infected with hepatitis C virus (HCV), only 20-30% clear the infection spontaneously. In the remaining 70% the infection persists, causing chronic liver inflammation and disease. It is well established that polymorphisms in host genes, especially in components of the innate immune response, contribute to the phenomenon of spontaneous HCV clearance. Retinoic acid inducible gene-I (RIG-I)-like helicases such as melanoma differentiation-associated gene 5 (MDA-5) are cytoplasmic sensors of viral RNA that are critical for triggering innate immune responses after infection with RNA viruses. We analyzed 14 nonsynonymous single-nucleotide polymorphisms in RIG-I-like helicase-pathway-genes comparing European patients who spontaneously cleared HCV (n = 285) or had persistent infection (n = 509). We found that polymorphic haplotypes in the MDA-5 gene IFIH1 encoding histidine at position 843 and threonine at position 946 strongly correlate with the resolution of HCV infection (odds ratio [OR]: 16.23; 95% confidence interval [CI]: 3.67-71.87; P = 1.1 × 10(-6) ). Overexpression of MDA-5 genetic variants in HEK 293 cells and in a tissue culture model of HCV infection revealed that the histidine 843/threonine 946 variant leads to increased baseline and ligand-induced expression of interferon-induced genes and confers an increased ability to suppress HCV replication.
CONCLUSION: These data suggest that MDA-5 plays a significant role in the defense against HCV and that polymorphisms in MDA-5 can influence the outcome of HCV infection.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25130193      PMCID: PMC4315306          DOI: 10.1002/hep.27344

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

Review 1.  Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Authors:  Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 4.  Immune signaling by RIG-I-like receptors.

Authors:  Yueh-Ming Loo; Michael Gale
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

Review 5.  Enteroviruses in the pathogenesis of type 1 diabetes.

Authors:  Sisko Tauriainen; Sami Oikarinen; Maarit Oikarinen; Heikki Hyöty
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 6.  Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.

Authors:  Manuel Romero-Gomez; Mohamed Eslam; Agustín Ruiz; Marta Maraver
Journal:  Liver Int       Date:  2011-01-30       Impact factor: 5.828

7.  Study of transcriptional effects in Cis at the IFIH1 locus.

Authors:  Hana Zouk; Luc Marchand; Constantin Polychronakos
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

8.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation.

Authors:  Qisheng Li; Abraham L Brass; Aylwin Ng; Zongyi Hu; Ramnik J Xavier; T Jake Liang; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

9.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  18 in total

1.  Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.

Authors:  Samira Asgari; Luregn J Schlapbach; Stéphanie Anchisi; Christian Hammer; Istvan Bartha; Thomas Junier; Geneviève Mottet-Osman; Klara M Posfay-Barbe; David Longchamp; Martin Stocker; Samuel Cordey; Laurent Kaiser; Thomas Riedel; Tony Kenna; Deborah Long; Andreas Schibler; Amalio Telenti; Caroline Tapparel; Paul J McLaren; Dominique Garcin; Jacques Fellay
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

Review 2.  Insights into antiviral innate immunity revealed by studying hepatitis C virus.

Authors:  Stacy M Horner
Journal:  Cytokine       Date:  2015-03-25       Impact factor: 3.861

3.  Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population.

Authors:  Candelaria Vergara; Chloe L Thio; David Thomas; Priya Duggal
Journal:  Hepatology       Date:  2015-07-28       Impact factor: 17.425

4.  Hepatitis C Virus. Strategies to Evade Antiviral Responses.

Authors:  Nandan S Gokhale; Christine Vazquez; Stacy M Horner
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

Review 5.  MDA5-filament, dynamics and disease.

Authors:  Yoandris del Toro Duany; Bin Wu; Sun Hur
Journal:  Curr Opin Virol       Date:  2015-02-09       Impact factor: 7.090

6.  An Inheritable variant of the innate immune receptor melanoma differentiation-associated gene 5 promotes clearance of hepatitis C virus.

Authors:  Yorgo Modis
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 7.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

8.  Spontaneous clearance of HCV accompanying hepatitis after liver transplantation.

Authors:  Tomomi Kogiso; Etsuko Hashimoto; Yuichi Ikarashi; Kazuhisa Kodama; Makiko Taniai; Nobuyuki Torii; Hiroto Egawa; Masakazu Yamamoto; Katsutoshi Tokushige
Journal:  Clin J Gastroenterol       Date:  2015-09-05

Review 9.  Recent advances in understanding hepatitis C.

Authors:  Florian Douam; Qiang Ding; Alexander Ploss
Journal:  F1000Res       Date:  2016-02-03

10.  Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5.

Authors:  Jade Louber; Joanna Brunel; Emiko Uchikawa; Stephen Cusack; Denis Gerlier
Journal:  BMC Biol       Date:  2015-07-28       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.